Sagimet Biosciences Inc.SGMTNASDAQ
LOADING
|||
R&D Expense Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
94.39%
↑ 139% above average
Average (5y)
39.41%
Historical baseline
Range
High:136.37%
Low:-20.63%
Volatility
398.4%
High variability
| Period | Value |
|---|---|
| 2024 | 94.39% |
| 2023 | -20.63% |
| 2022 | 28.85% |
| 2021 | 136.37% |
| 2020 | -2.49% |
| 2019 | 0.00% |